Back
Lululemon Athletica Vs. Aligos Therapeutics Industry Stock Comparison
Buy
72
LULU
Lululemon Athletica
Last Price:
$385.90
Seasonality Move:
1.27%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$43.62
Seasonality Move:
7.18%
Buy
72
Lululemon Athletica (LULU)
is a Buy
Is Lululemon Athletica a Buy, Sell or Hold?
-
The current Lululemon Athletica [LULU] share price is $385.69. The Score for LULU is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
LULU is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $39.34. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LULU Stock Price Chart
What is Lululemon Athletica's stock price today?
-
The Lululemon Athletica share price today is $385.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LULU is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $39.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
LULU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.64 | Buy |
| Relative Strength Index (14 RSI): | 64.15 | Buy |
| Chaikin Money Flow: | 174471 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (323.54 - 392.22) | Buy |
| Bollinger Bands (100): | (250.58 - 341.56) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.44 | Buy |
| Relative Strength Index (14 RSI): | 77.53 | Buy |
| Chaikin Money Flow: | -217768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.98 - 35.56) | Buy |
| Bollinger Bands (100): | (6.92 - 24.5) | Buy |
LULU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 383.27 | Buy |
| 20-day SMA: | 368.9 | Buy |
| 50-day SMA: | 332.75 | Buy |
| 200-day SMA: | 316.38 | Buy |
| 8-day EMA: | 381.88 | Buy |
| 20-day EMA: | 369.1 | Buy |
| 50-day EMA: | 339.75 | Buy |
| 200-day EMA: | 327.58 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.44 | Buy |
| 20-day SMA: | 31.12 | Buy |
| 50-day SMA: | 19.88 | Buy |
| 200-day SMA: | 16.4 | Buy |
| 8-day EMA: | 36.62 | Buy |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 23.66 | Buy |
| 200-day EMA: | 17.85 | Buy |
Lululemon Athletica Earnings Growth & LULU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $2.81 per share, an increase this year of $2.53 per share, and an increase next year of $1.71 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Lululemon Athletica Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||